Jump Financial »

Peregrine Pharmaceuticals shares owned by Jump Financial

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Jump Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $936k 144k 6.50
2022-09-30 $1.0M 54k 19.07

More positions owned by Jump Financial

Invesco Qqq Tr Etf (QQQ)
Ishares Tr Etf (IWM)
Spdr S&p 500 Etf Tr Etf (SPY)
Vanguard Index Fds Etf (VOO)
Ishares Tr Etf (TLT)
Proshares Tr Etf (SQQQ)
Ishares Tr Etf (IVV)
Proshares Tr Etf (PSQ)
Microsoft Corp Common Stock (MSFT)
Spdr Ser Tr Etf (SPLG)
Nvidia Corporation Common Stock (NVDA)
Proshares Tr Etf (SSO)
Amazon Common Stock (AMZN)
Proshares Tr Etf (TQQQ)
Direxion Shs Etf Tr Etf (SPXL)

View all positions for Jump Financial

Top funds holding Peregrine Pharmaceuticals

Millennium Management
Vanguard Group
AltraVue Capital
Royal Bank of Canada
Palisade Capital Management
Wellington Management Company
Punch & Associates Investment Management
AWM Investment Company
Kornitzer Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Sargent Investment Group
Goldman Sachs Group
B. Riley Asset Management
Two Sigma Investments

View all funds holding Peregrine Pharmaceuticals